Loading company…
Supreme Life develops diabetes management therapies and patient education services.
Founded in 2020, Beijing Jingyihe Biomedical Technology provides diabetes management solutions that combine therapies, scientific education, and patient case studies. It serves patients, clinics, and healthcare providers, primarily in urban China. In January 2026, the company raised an undisclosed amount of Series A+ funding from CITIC Med Fund to expand treatment centers and develop AI-assisted traditional Chinese medicine systems.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in